BioCentury
ARTICLE | Clinical News

EliA CCP regulatory update

October 30, 2006 8:00 AM UTC

FDA granted 510(k) clearance to EliA CCP to diagnose early stage rheumatoid arthritis (RA). EliA CCP is a fully automated assay for the measurement of cyclic citrullinated peptide (CCP) antibodies, a ...